Moreover, the biosensor was also highly sensitive to detect FGF21 in complex samples (i.e., serum sample), authenticating its potential to be used in NAFLD diagnosis. The gene discussed is FGF21; the disease is metabolic dysfunction-associated steatotic liver disease.